Avicenna Days (AAD) 2023
10/10/2023 - 12/10/2023
FREE, ONLINE, IN SILICO HEALTHCARE EVENT:
AVICENNA DAYS 2023
October 2023:
- Tuesday 10: “Uncovering the regulatory pathway”
- Wednesday 11: “Research & Technology: Building reliable models”
- Thursday 12: “Involving and serving the Patients”
Time: 14.00 - 18:30 CEST / 13.00 - 17.30 BST / 18.30 - 23.00 IST / 8.00 - 12.30 EDT / 7.00 - 11.30 CDT
Diversity & Inclusion in the In Silico Approaches
The 2023 Avicenna Days will bring together regulators, scientists, researchers, industry and academia leaders to update the entire healthcare community on recent progress and achievements related to the adoption and deployment of in silico methods.Prestigious delegates from the entire in silico community will present, debate, inspire and engage with the audience to accelerate medical innovation through Computer Modeling and Simulation (CM&S).
Don’t miss this opportunity to engage with in silico leaders: mark your calendar, register today and, join us on October 10, 11 and / or 12 to be an actor of the healthcare transformation.
Online Registration
Who should attend?
- Academic or industry researchers and any leader involved in medical and pharmaceutical innovation;
- Scientists and regulatory affairs professionals interested in digital evidence;
- Clinicians and medical staff willing to understand how in silico technology can help them in their daily activities;
- Patient associations keen on learning more about in silico methods, with a special focus on delivering faster safer and more affordable health care to the patient.
Why should you attend?
- Learn recent advances supporting in silico methods for research, regulatory and clinical activities, on the medical device, bio/pharma and treatment fields.
- Update on academic, industry and regulatory leaders’ visions and timelines for larger scale adoption of in silico medicine.
- Ask questions, express concerns, debate with experts and peers about important, immediate next steps to combine health care innovation and better patient safety.
Want to receive further information?
Please contact manager@avicenna-alliance.com
Avicenna Days 2023
Diversity & Inclusion in the In Silico Approaches
Programme
October 10th – Focus on Regulatory – «Uncovering the regulatory pathway»
14:00 - 14:05 Welcome
Roberta Maggi, Office Manager, Avicenna Alliance
14:05 - 14:20 Introduction to Avicenna Alliance
Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
14:20 - 14:35 Introduction to the topic
Cécile Rousseau, In Silico Application WG, Master of Ceremony, Avicenna Alliance, VCLS
14:35 - 14:50 "Adoption of Modelling and Simulation-based methods for High Impact applications: An European regulator’s perspective", Keynote Speaker, Flora Musuamba, Vice Chair Person, EMA
14:50 - 15:05 “Uncovering the MIDD Paired Meeting Pathway”, Keynote Speaker, Raj Madabushi, Associate Director, FDA 15:05 - 15:20 “In silico confidence: the regulatory journey for computational modeling and medical devices“, Keynote Speaker, Pras Pathmanathan, Senior Scientist, FDA
15:20 - 15:35 BREAK
15:35 - 15:50 "Charting the Future: Unveiling the Regulatory Complexities of In Silico Trials with the Regulatory Agencies”, Francesco Pappalardo, Full Professor, University of Catania, Mimesis
15:50 - 16:05 “A path towards a comprehensive regulatory framework for acceptance of in silico evidence (Countries experiences)”, Martha De Cunha, Policy Development WG, Avicenna Alliance, Edwards Lifesciences
16:05 - 16:20 "Going Towards Good Simulation Practices", Luca Emili, GSP Task Force, InSilicoTrials
16:20 - 16:30 "Artificial intelligence-driven drug development against autoimmune diseases", Case study, Philippe Moingeon, Head of Therapeutic Area, Servier
16:30 - 16:40 ‘Scoping and Validating an In Silico Clinical Trial: A Case Study on a Shoulder Stem",’Case study, Jeff Bischoff, Senior Research Director, Zimmer Biomet
16:40 - 16:50 “In Silico Advancements in Cardiovascular Device Design and Approval”, Case study, Simon Sonntag, Notified Bodies TF, Virtonomy
16:50 - 17:00 "In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials", Case study, Alejandro Frangi, UK In Silico Regulatory Innovation TF, University of Manchester
17:00 - 17:15 BREAK
17:15 - 18:00 Panel discussion / Round Table.
Moderator: Emmanuelle Voisin, Founder & CEO, VCLS
Speakers: Ulrike Schroeder, Senior Project Manager, DIN
Puja Myles, Director CPRD, MHRA
Payman Afshari, Senior Principal Engineer, J&J
Mark Palmer, Senior Chief Technologist for Healthcare, Ansys.
18:00 - 18:15 Wrap up
Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
October 11th – Focus on Research – «Building reliable models»
14:00 - 14:20 Introduction to tasks forces & community-based initiatives
Liesbet Geris, Research & Technology WG, Master of Ceremony, Avicenna Alliance, VPHi
14:20 - 14:50 “Why do we need Medical Digital Twins?”, Frank Rademakers, Keynote Speaker, Emeritus Professor Cardiology, KU Leuven
14:50 - 15:20 "Building digital twins for complex human diseases", Anna Niarakis, Professor, University of Toulouse III - Paul Sabatier, Center of Integrative Biology, Immune Digital Twin Consortium
15:20 - 15:35 "Supercomputer-based cardiac virtual human twins”, Mariano Vazquez, Co-founder, President, and CTO, ELEM Biotech
15:35 - 15:50 "Conception and evaluation of a biomechanical model of the lowerlimb", Antoine Perrier, Strategic and medical chief officer, Twinsight
15:50 - 16:10 BREAK
16:10 - 16:40 "Modeling and Simulation for Treatment Planning in Cardiovascular Disease in SimVascular", Keynote Speaker, Alison Marsden, Professor, Stanford University
16:40 - 16:55 "Responses of Hypertensive Virtual Population to Calcium Channel Blocker Treatment: Comparison to a Real Population", Robert Hester, Professor Emeritus, UMMC (University of Mississippi Medical Center).
16:55 - 17:00 Introduction to the round table – Marc Horner, Global Harmonization TF, Ansys
17:00 - 17:50 Panel discussion / Round Table.
Moderator: Marc Horner, Ansys
Speakers:
Kyriakos Hatzaras CEng Programme Officer – EU Policies
Frank Rademakers, KU Leuven
Anna Niarakis, University of Toulouse III
Alison Marsden, Stanford University
Liesbet Geris, VPHi
Thierry Marchal, Ansys
17:50 - 18:00 Wrap up
Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
October 12th – Focus on Patients / Clinicians – «Involving and serving the Patients»
14:00 - 14:05 Welcome
Roberta Maggi, Office Manager, Avicenna Alliance
14:05 - 14:25 Introduction to the topic
Cyrille Thinnes, Public & Patient Involvement TFL, Master of Ceremony, Avicenna Alliance, NUI Galway
14:25 - 14:45 "Clinical use of 3D modeling and simulation for preoperative planning in congenital heart surgery",
Keynote 3 David Hoganson, Assistant in Cardiac Surgery, Department of Cardiac Surgery, Boston Children’s Hospital
14:45 - 15:05 "Person Centered Health Care”, Keynote Speaker, Daniel de Schryver, Patient Engagement & Advocacy Lead, Janssen
15:05 - 15:25 "It's not just a headache", Keynote Speaker, Pascal Derrien, CEO, Migraine Ireland
15:25 - 15:40 BREAK
15:40 - 15:55 “Patient Involvement: Myth or indisputable necessity?”, Anne Thorez, Senior Director Patient Engagement, VCLS
15:55 - 16:10 “Use of VR technologies to enhance the clinical uptake of the digital twin”, Claudio Capelli, Research Associate, University College London
16:10 - 16:25 "Responsible Research and Innovationinin silico Medicine: Bridging the gap between science and public", Zita Van Horenbeeck, Social Scientist, VPHi
16:25 - 16:35 "My experience of being an Embedded Patient Researcher", Case study, Robert Joyce, MS Patient Advocate, Embedded Patient Researcher, National University of Ireland, Galway
16:35 - 16:45 "Case studies of PPI involvement in Cancer Research", Case study 2 Frances Drummond, Research Manager, Breakthrough Cancer Research
16:45 - 16:55 "PPI workshop at a scientific congress - the way forward?", Case study, Marlène Mengoni, Associate Professor, University of Leeds
16:55 - 17:05 "EUPATI – enhancing patient involvement in research through education", Case study, Maria Dutarte, Executive Director, EUPATI
17:05 - 17:20 BREAK
17:20 - 18:00 Panel discussion / Round Table
Moderator: Cyrille Thinnes, NUI Galway
Speakers:
Avril Kennan, CEO, Health Research Charities Ireland
Steve Levine, Chair of PPI Task Force, Sr. Director of Virtual Human Modeling, Dassault Systèmes
Veronica Popa, Digital Patient Engagement Manager, EURORDIS
18:00 - 18:15 Wrap up
Thierry Marchal, Secretary General, Avicenna Alliance, Ansys
REGISTER NOW!!!
Speakers
Thierry Marchal
Avicenna Alliance President and Secretary General
Program Director for Healthcare Solution, ANSYS, Inc.
SEND E-MAILRoberta Maggi
Avicenna Alliance Office Manager
Avicenna Alliance
SEND E-MAIL +39.351.8890319Cécile Rousseau
In Silico Application Working Group Leader
Senior Director, Nonclinical & Early Clinical Development, VCLS
SEND E-MAILEmmanuelle Voisin
In Silico Application Working Group Leader
Founder & CEO, Voisin Consulting Life Sciences (VCLS)
SEND E-MAILLiesbet Geris
Research & Technology Working Group Leader
Executive Director, VPH Institute
SEND E-MAILMartha De Cunha Maluf-Burgman
Policy Development Working Group Leader
Director Regulatory Affairs, Edwards Lifesciences
SEND E-MAILMarc Horner
Leader of the International Affairs WG & Chair of the Global Harmonization TF
Distinguished Engineer, Ansys
Luca Emili
Co-Chair of the Good Simulation Practice (GSP) Task Force
CEO, InSilicoTrials Technologies
Simon Sonntag
Co-chair of the Notified Bodies (NB) Task Force
CEO and Co-Founder, Virtonomy.
Cyrille Thinnes
Co-chair of the Public & Patient Involvement (PPI) Task Force
Researcher, National University of Ireland, Galway NUI Galway
Steven Levine
Co-chair of the Public & Patient Involvement (PPI) Task Force
Director of Virtual Human Modeling, Dassault Systèmes
Alejandro Frangi
Co-chair of the UK In Silico Regulatory Innovation Task Force
University of Manchester
Anne Thorez
Senior Director Patient Engagement
VCLS
Avril Kennan
CEO
Health Research Charities Ireland
Daniel De Schryver
Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa
Janssen
Francesco Pappalardo
Full Professor in Computer Science
University of Catania
Frances Drummond
Research Manager
Breakthrough Cancer Research
Marlène Mengoni
Associate Professor
University of Leeds
Pascal Derrien
CEO
Migraine Ireland
Pras Pathmanathan
Senior scientist
US Food and Drug Administration
Claudio Capelli
Research Associate
University College London (UCL)
Mark Palmer
Senior Chief Technologist for Healthcare
Ansys
Raj Madabushi
Associate Director, Guidance and Scientific Policy, Office of Clinical Pharmacology
OTS / CDER / FDA
Anna Niarakis
Full Professor
University of Toulouse III - Paul Sabatier, Center of Integrative Biology, Immune Digital Twin Consortium
David Hoganson
Assistant in Cardiac Surgery, Department of Cardiac Surgery
Boston Children’s Hospital
Flora Musuamba
Vice Chair person, Modelling and Simulation Working Party
EMA
Kyriacos Hatzaras
Programme Officer, EU Policies of Unit H3
European Commission Directorate-General CNECT
Maria Dutarte
Executive Director of the European Patients’ Academy
EUPATI
Robert Hester
President and CEO of HC Simulation, LLC
Professor Emeritus at University of Mississippi Medical Center
Zita Van Horenbeeck
Social Scientist, VPHi
Doctoral Researcher, KU Leuven (Life Sciences and Society Lab)
Antoine Perrier
Strategic and Medical Chief Officer
TwInsight
Frank Rademakers
Emeritus Professor Cardiology
KU Leuven
Jeffrey Bischoff
Senior Research Director (Biomechanics)
Zimmer Biomet
Robert Joyce
MS Patient Advocate, Embedded Patient Researcher
National University of Ireland, Galway
Veronica Popa
Digital Patient Engagement Manager
Eurordis
Alison Marsden
Professor in Bioengineering and Pediatrics
Stanford University
Puja Myles
Director, Clinical Practice Research Datalink (CPRD)
MHRA
Philippe Moingeon
Head of therapeutic area immuno-inflammation. Application of AI to drug development
Servier
Ulrike Schröder
Senior Project Manager
DIN
Payman Afshari
Sr. Principal Engineer
Johnson and Johnson, MEDTECH
Mariano Vazquez
Co-Founder, President, and CTO
ELEM Biotech